Spectral AI Has Provided Support To Nasdaq And The State Securities Authorities In Florida, Louisiana And Texas To Bring To Their Attention Potential Market Manipulation Of The Co's Common Stock, Primarily In The Form Of Naked Short Selling

6/24/24 8:16:10 AM ET

Medical/Dental Instruments

Health Care

Get the next $MDAI alert in real time by email

Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has provided support to Nasdaq and the state securities authorities in Florida, Louisiana and Texas to bring to their attention potential market manipulation of the Company's common stock, primarily in the form of naked short selling.

This inquiry is being led by Erich Spangenberg, a member of the Board of Directors and the Company's largest shareholder.

Get the next $MDAI alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MDAI

Date	Price Target	Rating	Analyst
1/23/2024	$4.00	Buy	BTIG Research

More analyst ratings

$MDAI
Financials

Live finance-specific insights

Spectral AI Announces 2024 Third Quarter Financial Results
Revenue Rose to $8.2 MillionCompany Reaffirms Timeline for Regulatory Submission to U.S. FDA Q3 2024 Overview Research & Development Revenue Rose 138% to $8.2 MillionLast Patient Out at Burn Centers for U.S. Burn Pivotal Study; Top Line Study Results Expected in Q4 2024U.S. FDA Submission on Track for Q2 2025Completed Proof-of-Concept Module for Wound Measurement Technology DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended S
11/6/24 4:05:26 PM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed
10/23/24 4:50:37 PM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Announces 2024 Second Quarter Financial Results
Second Quarter Revenue Totals $7.5 Million Total Enrollment Exceeds 85% for Burn Center Pivotal U.S. Clinical Trial Q2 2024 Overview Research & Development Revenue of $7.5 MillionCash Position of $6.9 MillionOn Track to Generate First Commercial Revenues in the U.K. Later this YearBurn Pivotal Study Nearing Completion Paving the Way for U.S. FDA Submission in Early 2025Announced Collaboration with PolyNovo Ltd. Providing Introduction to Australian MarketContinued Progress in Handheld Burn Wound Diagnostic TechnologyAdded to Russell Microcap® Index effective July 1, 2024 DALLAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a
8/12/24 4:05:09 PM ET
$MDAI
Medical/Dental Instruments
Health Care

$MDAI
Press Releases

Fastest customizable press release news feed in the world

Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research
DALLAS, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) (Spectral AI or the Company), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced its DeepView SnapShot® M device continues to develop based upon preliminary feedback from its usability study with the Brooke Army Medical Center and the U.S. Army Medical Research and Development Command's Institute of Surgical Research. This milestone positions Spectral AI as a game-changer in wound care diagnostics, addressing significant unmet needs in diverse markets, including the U.S. Department of Defense, home healthc
11/21/24 8:00:00 AM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
DALLAS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the successful completion of an approximate $5.0 million equity financing in an at-the-market transaction. The closing is to be completed in two tranches. Part of the proceeds will be used for the retirement of its outstanding obligations with Yorkville Advisors. This transaction supports Spectral AI's growth trajectory and progress toward a submission to the U.S. Food and Drug Administration ("FDA") for approval of
11/19/24 8:00:00 AM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Announces 2024 Third Quarter Financial Results
Revenue Rose to $8.2 MillionCompany Reaffirms Timeline for Regulatory Submission to U.S. FDA Q3 2024 Overview Research & Development Revenue Rose 138% to $8.2 MillionLast Patient Out at Burn Centers for U.S. Burn Pivotal Study; Top Line Study Results Expected in Q4 2024U.S. FDA Submission on Track for Q2 2025Completed Proof-of-Concept Module for Wound Measurement Technology DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended S
11/6/24 4:05:26 PM ET
$MDAI
Medical/Dental Instruments
Health Care

Spectral AI Set to Join Russell Microcap® Index
DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective following the closing of US equity markets on Friday, June 28, 2024 according to a preliminary list of additions posted Friday, May 24, 2024. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30, 2024 ranking them by total market capitalization. Members
5/29/24 8:31:22 AM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors
DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2024 Annual Meeting of Stockholders held on May 14, 2024 (the "AGM"). At the AGM, stockholders overwhelmingly approved each of the four proposals set forth by the Company. The voting results are detailed below. Six directors were elected to serve until the next Annual Meeting of Stockholders: Richard Cotton, Chairman of the Company's Board of DirectorsPeter M. Carlson, Chief Executive Officer of the
5/15/24 6:05:21 PM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
DALLAS, April 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer. Jeremiah has more than 20 years of medical device marketing experience, including global marketing and business strategy. Mr. Sparks will be responsible for both domestic and international product commercialization. "We are thrilled to have Jeremiah join the company as we move towards commercialization of DeepView," said Peter M. Carlson, CEO of Spectral AI.
4/1/24 9:00:00 AM ET
$MDAI
Medical/Dental Instruments
Health Care

Spectral AI Announces Total U.S. And International Patent Portfolio Now Stands At 26 Granted Patents And 38 Pending Applications
Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a 30% increase in its patent portfolio that strengthens and protects its proprietary, AI-driven DeepView System wound assessment platform. Total patents granted to the Company increased to 26 through July 8, 2024 from 20 at December 31, 2023, consisting of 12 U.S. and 14 international patents. These patents cover various aspects of the Company's DeepView System platform, including, but not limited to, tissue classification based on multi-spectral imaging, machine learning and he
7/24/24 8:00:52 AM ET
$MDAI
Medical/Dental Instruments
Health Care
Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has added three new U.S. Clinical Trial Sites for its 2024 Burn Pivotal Study: University Medical Center (UMC) Burn Center at Texas Tech University Health Sciences Center led by principal investigator Alan Pang, M.D., Tampa General Hospital Burn Center led by principal investigator Jared Troy, M.D., and University of South Alabama (USA) Health Emergency Department led by Andrew Bright, D.O.These new locations expand the total number of U.S. Clinical Trial Sites to 16, co
7/23/24 8:12:59 AM ET
$MDAI
Medical/Dental Instruments
Health Care
HC Wainwright & Co. Initiates Coverage On Spectral AI with Buy Rating, Announces Price Target of $3.5
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Spectral AI (NASDAQ:MDAI) with a Buy rating and announces Price Target of $3.5.
7/18/24 6:15:57 AM ET
$MDAI
Medical/Dental Instruments
Health Care

Spectral AI Has Provided Support To Nasdaq And The State Securities Authorities In Florida, Louisiana And Texas To Bring To Their Attention Potential Market Manipulation Of The Co's Common Stock, Primarily In The Form Of Naked Short Selling

Chat with this insight

Recent Analyst Ratings for $MDAI

$MDAI Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

BTIG Research initiated coverage on Spectral AI with a new price target

$MDAI Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

$MDAI Financials

Live finance-specific insights

Spectral AI Announces 2024 Third Quarter Financial Results

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

Spectral AI Announces 2024 Second Quarter Financial Results

$MDAI Press Releases

Fastest customizable press release news feed in the world

Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research

Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway

Spectral AI Announces 2024 Third Quarter Financial Results

$MDAI SEC Filings

SEC Form S-3 filed by Spectral AI Inc.

SEC Form 424B5 filed by Spectral AI Inc.

SEC Form 10-Q filed by Spectral AI Inc.

$MDAI Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Spangenberg Erich was granted 6,000 shares, increasing direct ownership by 0.96% to 628,574 units (SEC Form 4)

Micek Stan was granted 10,000 shares (SEC Form 4)

Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

$MDAI Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

$MDAI Leadership Updates

Live Leadership Updates

$MDAI Market Insights

Live Market Insights

Spectral AI Set to Join Russell Microcap® Index

Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors

Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

Spectral AI Announces Total U.S. And International Patent Portfolio Now Stands At 26 Granted Patents And 38 Pending Applications

Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment

HC Wainwright & Co. Initiates Coverage On Spectral AI with Buy Rating, Announces Price Target of $3.5

Recent Analyst Ratings for
$MDAI

$MDAI
Analyst Ratings

$MDAI
Insider Purchases

$MDAI
Financials

$MDAI
Press Releases

$MDAI
SEC Filings

$MDAI
Insider Trading

$MDAI
Large Ownership Changes

$MDAI
Leadership Updates

$MDAI
Market Insights